Literature DB >> 16150431

Determination of morphine in the plasma of addicts in using Zeolite Y extraction following high-performance liquid chromatography.

Mahmoud Ghazi-Khansari1, Rezvan Zendehdel, Morteza Pirali-Hamedani, Mohammad Amini.   

Abstract

BACKGROUND: The measurement of morphine in biological samples has become a routine in many clinical and forensic toxicology laboratories. A high-performance liquid chromatography (HPLC) method was developed for the determination of morphine in plasma.
METHODS: Samples were extracted using Zeolite Y column followed by reversed phase HPLC with fluorescence detection. This method was based on an ex-calibration procedure and was linear between 20 and 200 ng/ml of morphine. Blood from 10 male opiate addicts were obtained from Rosbeh Hospital. All of the male smoked opiate (heroin, opium) and cigarettes.
RESULTS: The mean total level 5 h after the last abuse was 152.4 ng/ml and 37.6 ng/ml at 10-15 h. The method was reliable for morphine determination in blood even after 5 half-lives after the last abuse.
CONCLUSIONS: This method is simple and rapid and may be useful for routine monitoring of plasma morphine concentration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150431     DOI: 10.1016/j.cccn.2005.07.002

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.

Authors:  Crystal R Leibrand; Jason J Paris; Austin M Jones; Quamrun N Masuda; Matthew S Halquist; Woong-Ki Kim; Pamela E Knapp; Angela D M Kashuba; Kurt F Hauser; MaryPeace McRae
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

2.  Different Roles of Beclin1 in the Interaction Between Glia and Neurons after Exposure to Morphine and the HIV- Trans-Activator of Transcription (Tat) Protein.

Authors:  Jessica Lapierre; Mohan K M Karuppan; Marissa Perry; Myosotys Rodriguez; Nazira El-Hage
Journal:  J Neuroimmune Pharmacol       Date:  2021-11-05       Impact factor: 7.285

3.  Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.

Authors:  Sylvia Fitting; David L Stevens; Fayez A Khan; Krista L Scoggins; Rachel M Enga; Patrick M Beardsley; Pamela E Knapp; William L Dewey; Kurt F Hauser
Journal:  J Pharmacol Exp Ther       Date:  2015-11-05       Impact factor: 4.030

4.  HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure.

Authors:  William D Marks; Jason J Paris; Aaron J Barbour; Jean Moon; Valerie J Carpenter; Virginia D McLane; Arianna R S Lark; Sara R Nass; Jingli Zhang; Viktor Yarotskyy; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  eNeuro       Date:  2021-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.